Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Clinical Mass Spectrometry Market 2019-2023 | Rise in Aging Population to Boost Demand | Technavio

Technavio Research
Posted on: 07 Dec 18

Technavio analysts forecast the global clinical mass spectrometry market to grow at a CAGR of close to 8% during the forecast period, according to their latest market research report. The growth momentum of the market is expected to accelerate in the year-over-year growth.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181207005298/en/

Technavio has released a new market research report on the global clinical mass spectrometry market for the period 2019-2023. (Graphic: Business Wire)

The increasing demand for clinical mass spectrometry in personalized medicine is one of the major trends being witnessed in the global clinical mass spectrometry market 2019-2023. Personalized medicine refers to providing medical treatment according to the individual characteristics of patients and offers the potential to detect diseases at an earlier stage when treatment can be effective. Personalized medicine increases the quality of clinical practice and targeted care pathways and ultimately reduces the overall healthcare costs. There is a growing popularity of using clinical mass spectrometers in the development of personalized medicine for the early detection of diseases and the selection of accurate treatment methods that can reduce mortality rates. Such developments will drive the growth of the market.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

According to Technavio analysts, one of the key factors contributing to the growth of the global clinical mass spectrometry market is the rise in aging population:

Global clinical mass spectrometry market: Rise in aging population

The increase in median age due to the increase in life expectancy has resulted in an increase in the aging population globally. As the elderly generally have low immunity and metabolism, they need to undergo diagnostic tests such as microbial testing on a regular basis. This results in an increased demand for clinical mass spectrometry that reveals details about the casual microorganisms, based on which, the physician decides the best course of treatment.

According to a senior analyst at Technavio, “In 2017, the World Bank highlighted that the number of people aged 65 years and above accounted for 8.69% of the global population. Thus, the increase in the aging population globally would drive the demand for microbial testing. Microbial identification with the help of clinical mass spectrometry provides several advantages such as it is easy to use and reduces the requirement for technical manpower. It is a reliable, rapid, and cost-effective technique for the identification of microorganisms.”

Global clinical mass spectrometry market: Segmentation analysis

The global clinical mass spectrometry market research report provides market segmentation by end user (healthcare and clinical research laboratory) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

The Americas held the largest share of the market in 2018, accounting for more than 41% share. It was followed by EMEA and APAC respectively. The Americas owns the largest share of the market owing to the increase in the number of research studies for discovering new therapies for diseases such as cancer.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181207005298/en/

Business Wire
www.businesswire.com

Last updated on: 07/12/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.